Evidence map›Paper›PMID 42589985›Full record

ArticleJournal of clinical medicine2026

Continuation Versus Discontinuation of Nonselective Beta-Blockers After Transjugular Intrahepatic Portosystemic Shunt Placement: A Real-World, Target-Trial Emulation Analysis.

Ali Emre Bardak, Ayse Ipek Bardak, Gizem Teker, Hind El Naamani, Elif Gokcek Uskudar, Volkan Senkal, Bilger Cavus, Nazli Begum Ozturk, Ahmet Gurakar

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ali Emre BardakDepartment of Medicine, Boston Medical Center-Brighton, Boston, MA 02135, USA.ORCID 0000-0002-3073-8538
Ayse Ipek BardakCenter for Computational Molecular Biology, Brown University, Providence, RI 02906, USA.
Gizem TekerBeth Israel Deaconess Medical Center, Boston, MA 02215, USA.
Hind El NaamaniDepartment of Medicine, Boston Medical Center-Brighton, Boston, MA 02135, USA.
Elif Gokcek UskudarDivision of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, MD 21218, USA.
Volkan SenkalDivision of Gastroenterology and Hepatology, Istanbul University, Istanbul 34452, Türkiye.ORCID 0000-0002-4363-7197
Bilger CavusDivision of Gastroenterology and Hepatology, Istanbul University, Istanbul 34452, Türkiye.
Nazli Begum OzturkDivision of Gastroenterology, Saint Louis University School of Medicine, St. Louis, MO 63104, USA.
Ahmet GurakarDivision of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, MD 21218, USA.ORCID 0000-0002-2221-9148

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cirrhosishepatic encephalopathynonselective beta-blockersportal hypertensiontransjugular intrahepatic portosystemic shunt

Identifiers

PMID42589985
PMCPMC13467356

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.